Find your next paid study

Elacestrant in Advanced Triple Positive Breast Cancer, a Phase II Evaluation (ELATE)

The purpose of this study to assess the safety and efficacy of elacestrant, a selective estrogen receptor degrader (SERD) and dual biologic therapy, trastuzuma…